Delivery Order SPE2DB22D3501-SPE2DB24FTV85
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,709.08 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 15 mmol/15 ml vials of Gadavist contrast agent. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 24, 2023. No set-aside designation was applied. As a prime contractor supporting DLA medical supply programs,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA). The $6,325.24 delivery order, issued on December 13, 2023 with a completion date of December 14, 2023, is for the supply of 100mL bottles of the contrast agent Visipaque 320 mg/ml to support DLA Troop Support Medical programs....
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $569 delivery order by the Defense Logistics Agency to provide 100mL bottles of Omnipaque 300 MG/ML injectable contrast media. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning August 10-11, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense responsible for procuring and providing nearly...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,512.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 100ml bottles of Omnipaque 350 mg/ml infusible contrast media. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 28, 2023. No set-aside designation was applied. As a prime contractor supporting DLA Troop Support Medical programs,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,875.49 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 20 vials of DOTAREM 10 MMOL/20 ML contrast media. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with all supplies delivered by November 28, 2023. No set-aside designation was applied to this order, which was issued against an existing...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $647 delivery order by the Defense Logistics Agency to provide 300ml bottles of 18% diluted Cystografin contrast solution. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period concluding on July 19, 2023. Pricing is firm fixed. The Defense Logistics Agency is the Department of Defense's primary logistics combat support agency,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,653.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 10 vials of Gadavist 10 mmol/10 ml contrast agent. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 30, 2023. No set-aside designation was applied to this order, which was issued against an existing...
- Amerisourcebergen Drug Corp has received a $5,195.20 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 7.5 mmol/7.5 ml vials of Gadavist contrast agent. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to support military treatment programs from its headquarters in Conshohocken, Pennsylvania by November 29, 2023. No set-aside designation was applied to this award issued against an existing DLA contract...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,882.27 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 29, 2025, with an ultimate completion date of December 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,164 under the Defense Logistics Agency Troop Support Medical indefinite delivery/indefinite quantity contract. The delivery order is to provide 4561894407 units of 1 gram/200ml vials of an unspecified pharmaceutical to support Defense Logistics Agency medical programs. Performance will occur at Amerisourcebergen's facility in Conshohocken,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTV85Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA). The $17,364 delivery order is for the supply of 100ml bottles of the contrast agent Iodixanol 320mg/ml to support DLA Troop Support Medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion scheduled for December 14, 2023. No set aside designation was applied to this award made on December 13, 2023. Amerisourcebergen Drug Corp routinely provides pharmaceuticals and medical supplies to DLA in support of military treatment facilities and initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 12/13/23 |